Topotecan for relapsed small cell lung cancer: retrospective study

被引：0
|
作者：
Alegria, Ana M. [1 ]
Rodrigues, Cidalia [2 ]
Teixeira, Encarnacao [1 ]
Barata, Fernando [2 ]
Sotto-Mayor, Renato [1 ]
Figueiredo, Ana [2 ]
Rito, Emilia [1 ]
Almeida, Antonio B. [1 ]
机构：
[1] Hosp Santa Maria, Lisbon, Portugal
[2] Ctr Hosp Coimbra, Coimbra, Portugal
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S805 / S805
页数：1
相关论文
共 50 条
  • [41] Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients
    Horita, Nobuyuki
    Yamamoto, Masaki
    Sato, Takashi
    Tsukahara, Toshinori
    Nagakura, Hideyuki
    Tashiro, Ken
    Shibata, Yuji
    Watanabe, Hiroki
    Nagai, Kenjiro
    Inoue, Miyo
    Nakashima, Kentaro
    Ushio, Ryota
    Shinkai, Masaharu
    Kudo, Makoto
    Kaneko, Takeshi
    SCIENTIFIC REPORTS, 2015, 5
  • [42] Phase II Trial of metronomic Temozolomide and Topotecan in patients with relapsed and/or refractory Small Cell Lung Cancer.
    Bhattacharyya, Gouri Shankar
    Parikh, Purvish M.
    Biswas, Ghanashyam
    Bondarde, Shailesh A.
    Malhotra, Hemant
    Vora, Amish
    Govindbabu, K.
    Ranade, Anantbhushan A. B.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S743 - S743
  • [43] Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG)
    Christodoulou, C
    Kalofonos, HP
    Briasoulis, E
    Bafaloukos, D
    Makatsoris, T
    Koutras, A
    Skarlos, DV
    Samantas, E
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (02) : 207 - 212
  • [44] A phase I study of weekly topotecan (T) in combination with sorafenib (S) for treatment of relapsed or refractory small cell lung cancer (SCLC).
    Leach, J. W.
    Swenson, K.
    Anderson, E.
    Menge, M. R.
    Tsai, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG)
    Christos Christodoulou
    Haralambos P. Kalofonos
    Evangelos Briasoulis
    Dimitrios Bafaloukos
    Thomas Makatsoris
    Angelos Koutras
    Dimosthenis V. Skarlos
    Epaminondas Samantas
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 207 - 212
  • [46] Treatment of relapsed small cell lung cancer
    Postmus, PE
    Smit, EF
    SEMINARS IN ONCOLOGY, 2001, 28 (02) : 48 - 52
  • [47] A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer
    Chiappori, Alberto A.
    Otterson, Gregory A.
    Dowlati, Afshin
    Traynor, Anne M.
    Horn, Leora
    Owonikoko, Taofeek K.
    Ross, Helen J.
    Hann, Christine L.
    Abu Hejleh, Taher
    Nieva, Jorge
    Zhao, Xiuhua
    Schell, Amichael
    Sullivan, Daniel M.
    ONCOLOGIST, 2016, 21 (10): : 1163 - 1164
  • [48] Topotecan in the treatment of recurrent small-cell lung cancer
    Denisso, Tadeusz
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2006, 2 (03): : 99 - 104
  • [49] Topotecan as salvage therapy of refractory small cell lung cancer
    Hatabay, Nilgun
    Erdal, Nuray
    Ece, Ferah
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S813 - S813
  • [50] Therapy of small cell lung cancer with emphasis on oral topotecan
    Pirker, Robert
    Berzinec, Peter
    Brincat, Stephen
    Kasan, Peter
    Ostoros, Gyula
    Pesek, Milos
    Plate, Signe
    Purkalne, Gunta
    Rooneem, Regina
    Skrickova, Jana
    Stanculeanu, Dana
    Timcheva, Constanta
    Tzekova, Valentina
    Zakotnik, Branko
    Zielinski, Christoph C.
    Zwitter, Matjaz
    LUNG CANCER, 2010, 70 (01) : 7 - 13
12345